2Seventy Bio IncNASDAQ:TSVT
- LAST PRICE4.9850
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.6200/ 2
- Ask / Lots4.9900/ 1
- Open / Previous Close0.0000 / 4.9850
- Day Range---
- 52 Week Range
- Volume2
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TSVT |
|---|---|---|
| 09:32 ET | 3041 | 4.9601 |
| 09:34 ET | 5823 | 5.01 |
| 09:36 ET | 1549 | 5 |
| 09:38 ET | 3610 | 5.01 |
| 09:39 ET | 1382 | 5.0591 |
| 09:41 ET | 3531 | 5.0899 |
| 09:43 ET | 1716 | 5.06 |
| 09:45 ET | 800 | 5.0499 |
| 09:48 ET | 300 | 5.03 |
| 09:50 ET | 1279 | 5.02 |
| 09:52 ET | 7080 | 5.07 |
| 09:54 ET | 3800 | 5.08 |
| 09:56 ET | 600 | 5.09 |
| 09:57 ET | 877 | 5.07 |
| 09:59 ET | 800 | 5.07 |
| 10:01 ET | 2200 | 5.03 |
| 10:03 ET | 1600 | 5.03 |
| 10:06 ET | 1668 | 5.03 |
| 10:08 ET | 830 | 5.03 |
| 10:10 ET | 1206 | 5.0599 |
| 10:12 ET | 200 | 5.045 |
| 10:14 ET | 700 | 5.05 |
| 10:15 ET | 527 | 5.0505 |
| 10:17 ET | 1300 | 5.0407 |
| 10:19 ET | 200 | 5.04 |
| 10:21 ET | 922 | 5.04 |
| 10:24 ET | 3380 | 5.01 |
| 10:26 ET | 1000 | 5.01 |
| 10:28 ET | 690 | 5.005 |
| 10:30 ET | 500 | 5.005 |
| 10:32 ET | 703 | 5.01 |
| 10:33 ET | 2251 | 5.0001 |
| 10:37 ET | 2757 | 5.05 |
| 10:39 ET | 618 | 5.04 |
| 10:42 ET | 2456 | 5.04 |
| 10:44 ET | 1623 | 5.075 |
| 10:46 ET | 300 | 5.08 |
| 10:48 ET | 2250 | 5.0602 |
| 10:50 ET | 110 | 5.055 |
| 10:51 ET | 300 | 5.05 |
| 10:53 ET | 413 | 5.02 |
| 10:55 ET | 100 | 5.03 |
| 11:00 ET | 288 | 5.025 |
| 11:02 ET | 1000 | 5.035 |
| 11:06 ET | 2580 | 5.071 |
| 11:08 ET | 157 | 5.0702 |
| 11:09 ET | 607 | 5.065 |
| 11:11 ET | 1300 | 5.0705 |
| 11:13 ET | 1289 | 5.07 |
| 11:15 ET | 100 | 5.07 |
| 11:18 ET | 200 | 5.07 |
| 11:22 ET | 200 | 5.065 |
| 11:24 ET | 100 | 5.065 |
| 11:26 ET | 818 | 5.065 |
| 11:29 ET | 700 | 5.07 |
| 11:31 ET | 700 | 5.075 |
| 11:33 ET | 400 | 5.095 |
| 11:38 ET | 647 | 5.105 |
| 11:40 ET | 615 | 5.09 |
| 11:42 ET | 2141 | 5.05 |
| 11:44 ET | 2600 | 5.065 |
| 11:45 ET | 250 | 5.0601 |
| 11:47 ET | 100 | 5.0699 |
| 11:49 ET | 300 | 5.06 |
| 11:51 ET | 310 | 5.055 |
| 11:56 ET | 793 | 5.0609 |
| 11:58 ET | 200 | 5.065 |
| 12:00 ET | 600 | 5.07 |
| 12:07 ET | 749 | 5.055 |
| 12:09 ET | 700 | 5.06 |
| 12:12 ET | 304 | 5.055 |
| 12:16 ET | 100 | 5.055 |
| 12:20 ET | 1038 | 5.045 |
| 12:21 ET | 5700 | 5.0413 |
| 12:23 ET | 100 | 5.045 |
| 12:25 ET | 800 | 5.03 |
| 12:27 ET | 900 | 5.01 |
| 12:30 ET | 700 | 5.005 |
| 12:32 ET | 4993 | 4.9912 |
| 12:34 ET | 1200 | 4.995 |
| 12:36 ET | 1654 | 4.995 |
| 12:39 ET | 500 | 4.995 |
| 12:41 ET | 1000 | 4.995 |
| 12:43 ET | 10749 | 4.975 |
| 12:45 ET | 1004 | 4.965 |
| 12:48 ET | 1105 | 4.96 |
| 12:50 ET | 4905 | 4.955 |
| 12:52 ET | 1900 | 4.9501 |
| 12:54 ET | 4818 | 4.96 |
| 12:56 ET | 2205 | 4.965 |
| 12:57 ET | 100 | 4.97 |
| 01:01 ET | 2850 | 4.965 |
| 01:03 ET | 1419 | 4.975 |
| 01:08 ET | 100 | 4.975 |
| 01:10 ET | 3000 | 4.9705 |
| 01:12 ET | 100 | 4.98 |
| 01:14 ET | 200 | 4.98 |
| 01:15 ET | 100 | 4.98 |
| 01:17 ET | 1604 | 4.9783 |
| 01:19 ET | 618 | 4.97 |
| 01:21 ET | 200 | 4.975 |
| 01:24 ET | 1400 | 4.975 |
| 01:26 ET | 200 | 4.975 |
| 01:28 ET | 400 | 4.975 |
| 01:30 ET | 200 | 4.975 |
| 01:32 ET | 200 | 4.975 |
| 01:33 ET | 207 | 4.9712 |
| 01:35 ET | 900 | 4.975 |
| 01:37 ET | 921 | 4.975 |
| 01:39 ET | 396 | 4.97 |
| 01:42 ET | 700 | 4.975 |
| 01:44 ET | 418 | 4.975 |
| 01:46 ET | 5179 | 5.01 |
| 01:50 ET | 425 | 5.0095 |
| 01:53 ET | 1600 | 4.99 |
| 01:55 ET | 100 | 4.995 |
| 01:57 ET | 14358 | 5.015 |
| 02:00 ET | 600 | 5.025 |
| 02:04 ET | 444 | 5.0436 |
| 02:06 ET | 100 | 5.05 |
| 02:08 ET | 100 | 5.045 |
| 02:09 ET | 2333 | 5.045 |
| 02:11 ET | 100 | 5.035 |
| 02:13 ET | 300 | 5.0331 |
| 02:15 ET | 1049 | 4.99 |
| 02:18 ET | 1000 | 4.995 |
| 02:20 ET | 100 | 4.995 |
| 02:22 ET | 100 | 4.995 |
| 02:24 ET | 3498 | 4.99 |
| 02:26 ET | 100 | 4.995 |
| 02:27 ET | 400 | 4.995 |
| 02:29 ET | 433 | 4.9903 |
| 02:31 ET | 900 | 4.995 |
| 02:33 ET | 200 | 4.995 |
| 02:36 ET | 300 | 4.995 |
| 02:40 ET | 1596 | 4.99 |
| 02:47 ET | 200 | 5 |
| 02:54 ET | 2271 | 4.985 |
| 02:56 ET | 3206 | 4.995 |
| 02:58 ET | 100 | 4.995 |
| 03:00 ET | 500 | 4.995 |
| 03:02 ET | 620 | 4.9901 |
| 03:03 ET | 400 | 4.995 |
| 03:05 ET | 100 | 5 |
| 03:09 ET | 14408 | 5.005 |
| 03:12 ET | 3024 | 5.005 |
| 03:14 ET | 100 | 5.005 |
| 03:16 ET | 300 | 5.01 |
| 03:18 ET | 2301 | 5.0001 |
| 03:20 ET | 400 | 5.005 |
| 03:21 ET | 2163 | 5.01 |
| 03:23 ET | 841 | 5.01 |
| 03:27 ET | 631 | 5.01 |
| 03:30 ET | 1500 | 5.02 |
| 03:32 ET | 1300 | 5.015 |
| 03:34 ET | 100 | 5.015 |
| 03:36 ET | 200 | 5.015 |
| 03:38 ET | 400 | 5.02 |
| 03:39 ET | 2867 | 5.035 |
| 03:41 ET | 200 | 5.035 |
| 03:43 ET | 200 | 5.035 |
| 03:45 ET | 935 | 5.03 |
| 03:48 ET | 5239 | 5.015 |
| 03:50 ET | 4700 | 5.02 |
| 03:52 ET | 12290 | 4.985 |
| 03:54 ET | 500 | 4.985 |
| 03:56 ET | 3955 | 4.985 |
| 03:57 ET | 14223 | 4.98 |
| 03:59 ET | 5010 | 4.985 |
Apr 8, 2024
DJ 2seventy bio Is Maintained at Buy by Citigroup, from 6:23PM ET on Monday Apr 08, 2024 by Dow Jones
6:23PM ET on Monday Apr 08, 2024 by Dow Jones
Apr 5, 2024
DJ Bristol Myers, 2seventy Get FDA OK for Earlier Abecma Use in Multiple Myeloma, from 9:17AM ET on Friday Apr 05, 2024 by Dow Jones
9:17AM ET on Friday Apr 05, 2024 by Dow JonesU.S. FDA Approves Bristol Myers Squibb and 2seventy bio's Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy, from 9:05AM ET on Friday Apr 05, 2024 by Dow Jones
9:05AM ET on Friday Apr 05, 2024 by Dow Jones
Apr 1, 2024
*DJ 2seventy Bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron, from 7:30AM ET on Monday Apr 01, 2024 by Dow Jones
7:30AM ET on Monday Apr 01, 2024 by Dow Jones2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron, from 7:30AM ET on Monday Apr 01, 2024 by Dow Jones
7:30AM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
2Seventy Bio Inc | 255.8M | -1.1x | --- |
CytomX Therapeutics Inc | 133.4M | -103.0x | --- |
G1 Therapeutics Inc | 225.0M | -4.5x | --- |
Chromadex Corp | 296.0M | -59.6x | --- |
Rigel Pharmaceuticals Inc | 201.7M | -8.0x | --- |
Alimera Sciences Inc | 185.3M | -1.6x | --- |
Company Information
2seventy bio, Inc. is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The Company is focused on the commercialization and development of Abecma (idecabtagene vicleucel). Abecma is its B cell maturation antigen (BCMA)-targeted CAR T cell therapy for multiple myeloma, in collaboration with their partner Bristol Myers Squibb (BMS). ABECMA is a BCMA-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. Abecma uses a lentiviral vector (LVV), to deliver a chimeric antigen receptor (CAR), with the potential to program a patient’s own T cells to recognize the plasma cell specific BCMA, protein on the cell surface.
Contact Information
- Headquarters
- 60 Binney StreetCAMBRIDGE, MA, United States 02210
- Phone
- 339-499-9300
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Daniel Lynch
- President, Chief Executive Officer, Director
- Nick Leschly
- Chief Financial Officer, Chief Operating Officer
- William Baird
- Independent Director
- Eli Casdin
- Independent Director
- Sarah Glickman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $255.8M |
|---|---|
Revenue (TTM) | $100.4M |
Shares Outstanding | 51.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-4.41 |
Book Value | $5.04 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -236.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
